Not bad today |
I think there is accumulation going on here. Outstanding share are very low. Someone is looking to get more. Does anybody have level 2 to see if there is a big order ? |
Trading update was encouraging imo. Let's hope for another day of recovery |
Another blue day |
Pets at home 17per cent up today shows that pets business market is good. Future should be good for animalcare |
Wow 10000 share 145p. Big trade |
6000 shares .. wow that is a big trade |
Something is going on |
Is it not time to be investing in this one - or is ANCR still toxic?
I paid 2.14 in April this year when the price slumped hoping for a quick trading profit but now they are looking (IMO) like possibly one for the portfolio.
Have you all lost the faith? |
never liked the merger with Ecuphar, it transformed a simple business to a complicated |
What a disaster this has been for shareholders! I'm glad I sold out last June. I am not sure what price (if any) it would be good value to buy back again.
3800 |
Second that |
Coverage in the Mail on Sunday today. |
Maybe - it's their acquisition philosophy that's the killer for me.Pity ANCR looked a good long term hold. |
might expect now that Ecuphar is a public co, margins might improve hopefully as the Directors take less out and there might be some synergies to be realised with Animalcare? |
MW - I think it's a bad deal because:
- they've paid a very hefty multiple;
- there's no demonstrable evidence that the acquired company is growing organically - it will continue on an acquisition spree, the admission document is clear about that - these really end well;
- there's now quite a lot of debt on the balance sheet;
- margins are very thin; and
- it's not clear why Animalcare have done this. |
too early to say whether it will be bad for holders; could reach such a conclusion may be in a year or two
am disappointed that Ecuphar has obtained a lot of goodies without paying eg a listing on the stock market and effectively taken over ANCR without paying any sort of premium |
I've sold out too, it's an unbelevably bad deal for shareholders. 3800 |
I'm out too. It's been a great share but I don't think this deal adds up. I don't like how it's being rushed through - why? Why the massive urgency to buy an unquoted company? I don't like how control is effectively being given to two people I've never heard of. I don't like how they have gone from being in a profitable niche to what seems like massively overpaying for a reverse takeover. And I don't like how private shareholders were locked out of a placing at a large discount. And I don't like how a significant cash balance has been turned into debt (if I read it correctly).
It's a shame because it was a great company and I thought had more promise to come. Best of luck to remaining holders. |
Ecuphar have much lower profit margins. I am struggling with this one. They are paying £135m for a company earning £3.5m, so PE of around 38.I've decided to sell out as this is a completely different proposition now. Might work out well but happy to watch from sidelines for now. |
got an email to say trading had recommenced, down 20p so it could have been worse, not best pleased but not expecting the management to be interested. 3800 |
I'm presuming that this is a move to avoid the consequences of Brexit. |
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Hot Features
Premium
